Approval · Notice of Compliance 7971 · 2006
ACTONEL PLUS CALCIUM: Notice of Compliance 7971
Issued May 17, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7971
- Date
- May 17, 2006
- Company
- Procter & Gamble Pharmaceuticals Canada, IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Risedronate: bone metabolism regulator; calcium: calcium supplement
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTONEL PLUS CALCIUM | 02279657 | Cancelled Post Market |
Medicinal ingredients
- RISEDRONATE SODIUM 35 MG per TAB
- CALCIUM CARBONATE 500 MG per TAB